广州医学院学报
廣州醫學院學報
엄주의학원학보
ACADEMIC JOURNAL OF GUANGZHOU MEDICAL COLLEGE
2014年
1期
22-24
,共3页
袁玉莲%戴立华%冯定安%何汉源
袁玉蓮%戴立華%馮定安%何漢源
원옥련%대립화%풍정안%하한원
胺碘酮%索他洛尔%快速室上性心律失常
胺碘酮%索他洛爾%快速室上性心律失常
알전동%색타락이%쾌속실상성심률실상
amiodarone%sotalol%rapid supraventricular arrhythmia
目的:探讨胺碘酮联合索他洛尔救治快速室上性心律失常的临床疗效。方法:选取2010年8月至2013年10月广州市荔湾区第二人民医院收治的128例快速室上性心律失常患者作为研究对象,随机分为对照组(胺碘酮)和观察组(胺碘酮+索他洛尔),每组各64例。观察两组患者的临床疗效及药物起效时间、治疗后心率、窦性心律复转率等指标。结果:观察组有效率为94%(60/64),高于对照组的80%(51/64);观察组药物起效时间及治疗后心率均显著低于对照组;窦性心律复转率明显高于对照组;上述指标比较,差异均有统计学意义( P<0.05)。结论:胺碘酮联合索他洛尔治疗快速室上性心律失常起效快、效果好。
目的:探討胺碘酮聯閤索他洛爾救治快速室上性心律失常的臨床療效。方法:選取2010年8月至2013年10月廣州市荔灣區第二人民醫院收治的128例快速室上性心律失常患者作為研究對象,隨機分為對照組(胺碘酮)和觀察組(胺碘酮+索他洛爾),每組各64例。觀察兩組患者的臨床療效及藥物起效時間、治療後心率、竇性心律複轉率等指標。結果:觀察組有效率為94%(60/64),高于對照組的80%(51/64);觀察組藥物起效時間及治療後心率均顯著低于對照組;竇性心律複轉率明顯高于對照組;上述指標比較,差異均有統計學意義( P<0.05)。結論:胺碘酮聯閤索他洛爾治療快速室上性心律失常起效快、效果好。
목적:탐토알전동연합색타락이구치쾌속실상성심률실상적림상료효。방법:선취2010년8월지2013년10월엄주시려만구제이인민의원수치적128례쾌속실상성심률실상환자작위연구대상,수궤분위대조조(알전동)화관찰조(알전동+색타락이),매조각64례。관찰량조환자적림상료효급약물기효시간、치료후심솔、두성심률복전솔등지표。결과:관찰조유효솔위94%(60/64),고우대조조적80%(51/64);관찰조약물기효시간급치료후심솔균현저저우대조조;두성심률복전솔명현고우대조조;상술지표비교,차이균유통계학의의( P<0.05)。결론:알전동연합색타락이치료쾌속실상성심률실상기효쾌、효과호。
Objective:To investigate the clinical utility of amiodarone combined with sotalol for rapid supraventricular arrhythmia ( RSA ) . Methods: Between August 2010 and October 2013, we recruited 128 patients with RSA from Second People’ s Hospital of Liwan District, Guangzhou. Patients were randomly assigned to be treated with oral amiodarone therapy alone ( control group, n=64) or in combination with sotalol ( treatment group, n=64) . The efficacy in terms of time of onset, post treatment heart rate and, the rate of sinus complex transfer were assessed. Results:The effective rate was higher in treatment group (93.75% (60/64) vs. 79.69%(51/64)) than control group (P<0.05). The treatment group was associated with a shorter time of onset, a lower level of heart rate and higher rate of sinus rhythm ( all P<0.05) . Conclusion:Amiodarone combined with sotalol is characterized by an ideal efficacy in patients with RSA.